Target intelligence / Profile preview

Nicotinic acetylcholine receptor subunit alpha-10 (CHRNA10)

Target
CHRNA10
Molecular classification
Ion channel, Receptor
01

Overview

The nicotinic acetylcholine receptor subunit alpha-10 (α10) is a structural component of heteromeric α9α10 nAChRs primarily expressed in cochlear hair cells, where it assembles with α9 subunits to form ligand-gated ion channels essential for olivocochlear efferent neurotransmission. These receptors respond to acetylcholine released from olivocochlear terminals, enabling calcium influx that activates small-conductance potassium channels, hyperpolarizes outer hair cells, and suppresses cochlear amplification to protect against noise or enhance signal detection. Unlike homomeric α9 receptors, which produce weak currents and fail to support normal synaptic function or innervation in vivo, α10 is required for robust channel properties, proper efferent synapse development, and maintenance of auditory circuit integrity, as evidenced by knockout mice showing disorganized innervation, failed distortion product suppression, and residual low-amplitude responses. α10 expression extends to select brain regions including frontal cortex, medulla oblongata, and hippocampus, with compensatory regulation alongside α7 and α9 subunits, and presence in neuronal mitochondria. Although not directly linked to specific diseases in the data, disruptions impair auditory processing, highlighting its role in sensory physiology rather than broad therapeutic targeting.

Other names
alpha-10 nAChR subunitα10 nAChR subunitneuronal acetylcholine receptor subunit alpha-10
02

Biological functions

Signal transductionAuditory signal modulationSynaptic transmission
03

Disease associations

Hearing impairmentNeurodegenerative disease
04

Safety considerations

Potential disruption of olivocochlear innervation and auditory function if targetedα10 knockout leads to abnormal synaptic morphology and reduced efferent suppression

Beyond the preview

Go deeper on Nicotinic acetylcholine receptor subunit alpha-10 (CHRNA10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicotinic acetylcholine receptor subunit alpha-10 (CHRNA10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call